• Haoxi Health held an extraordinary general meeting on June 2, 2026.
• Shareholders authorized a sharp increase in authorized share capital to US$ 35.2 trillion, from US$ 384.25 million.
• They adopted an eighth amended and restated memorandum and articles to reflect the share-capital increase and a quorum change.
• They approved a potential share consolidation, giving the board discretion to set an aggregate ratio from 1-for-2 up to 1-for-8,000 within two years.
• They also approved a further amendment to the memorandum and articles tied to any consolidation, plus authority to adjourn the meeting if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-065289), on June 04, 2026, and is solely responsible for the information contained therein.